INCY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 17.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,787,827.45

Incyte Insider Trading History Chart

Incyte Share Price & Price History

^$78.96

▼ -1.52 (-1.89%)

As of 11/14/2024 03:58 PM ET

Days: 30 | 90 | 365

Trump’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

Incyte Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/6/2024	Barry P Flannelly	EVP	Sell	3,680	$79.68	$293,222.40	58,042
9/12/2024	Jonathan Elliott Dickinson	EVP	Sell	8,450	$62.36	$526,942.00	36,390
9/12/2024	Thomas Tray	Insider	Sell	572	$62.94	$36,001.68	24,825
7/25/2024	Vijay K. Iyengar	EVP	Sell	15,571	$70.00	$1,089,970.00	36,701
7/16/2024	Barry P Flannelly	EVP	Sell	1,306	$64.19	$83,832.14	58,042
7/9/2024	Barry P Flannelly	EVP	Sell	8,148	$60.00	$488,880.00	50,534
6/12/2024	Barry P Flannelly	EVP	Sell	19,164	$60.00	$1,149,840.00	66,377
6/6/2024	Thomas Tray	Insider	Sell	1,093	$58.91	$64,388.63	21,634
1/2/2024	Vijay K. Iyengar	EVP	Sell	657	$65.00	$42,705.00	43,412
12/12/2023	Thomas Tray	Insider	Sell	210	$57.36	$12,045.60	24,503
1/30/2023	Maria E. Pasquale	EVP	Sell	60,024	$84.74	$5,086,433.76	68,524
1/26/2023	Vijay K. Iyengar	EVP	Sell	7,000	$85.00	$595,000.00	42,835
1/4/2023	Steven H. Stein	EVP	Sell	28,399	$79.78	$2,265,672.22	109,021
12/23/2022	Vijay K. Iyengar	EVP	Sell	17,324	$80.80	$1,399,779.20	37,855
12/19/2022	Thomas Tray	Insider	Sell	1,223	$82.16	$100,481.68	16,606
7/22/2022	Thomas Tray	Insider	Sell	1,564	$83.13	$130,015.32	17,702
7/7/2022	Vijay K. Iyengar	EVP	Sell	5,787	$79.38	$459,372.06	40,313
4/8/2022	Barry P Flannelly	EVP	Sell	43,993	$83.49	$3,672,975.57	65,163
3/10/2022	Bros. Advisors Lp Baker	Director	Buy	218,563	$73.13	$15,983,512.19
3/8/2022	Bros. Advisors Lp Baker	Director	Buy	100,000	$70.67	$7,067,000.00
2/22/2022	Bros. Advisors Lp Baker	Director	Buy	99,800	$68.07	$6,793,386.00
2/17/2022	Bros. Advisors Lp Baker	Director	Buy	292,972	$67.74	$19,845,923.28
1/31/2022	Jonathan Elliott Dickinson	EVP	Sell	7,375	$74.19	$547,151.25
1/7/2022	Paula J. Swain	EVP	Sell	10,870	$73.31	$796,879.70
12/23/2021	Wendy L. Dixon	Director	Sell	20,000	$22.05	$441,000.00
12/17/2021	Bros. Advisors Lp Baker	Director	Buy	1,075,872	$72.80	$78,323,481.60
12/15/2021	Bros. Advisors Lp Baker	Director	Buy	350,332	$71.51	$25,052,241.32

“This Changes Everything” - Trump Hands Millions Massive IRS Gift

From Colonial Metals | Ad

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!

SEC Filings (Institutional Ownership Changes) for Incyte (NASDAQ:INCY)

96.97% of Incyte stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Incyte Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2024	Verition Fund Management LLC	40,467	$2.68M	0.0%	N/A	0.021%
11/14/2024	Captrust Financial Advisors	5,784	$0.38M	0.0%	-21.5%	0.003%
11/14/2024	Rockefeller Capital Management L.P.	41,868	$2.77M	0.0%	-0.4%	0.022%
11/14/2024	Martingale Asset Management L P	3,692	$0.24M	0.0%	-5.3%	0.002%
11/14/2024	Northwest & Ethical Investments L.P.	30,764	$2.03M	0.1%	-17.4%	0.016%
11/14/2024	Vinva Investment Management Ltd	12,108	$0.80M	0.0%	-70.1%	0.006%
11/14/2024	Public Sector Pension Investment Board	6,622	$0.44M	0.0%	+4.7%	0.003%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	1,379,465	$91.18M	0.0%	-24.1%	0.716%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	160,415	$10.60M	0.0%	+30.1%	0.083%
11/14/2024	MetLife Investment Management LLC	41,973	$2.77M	0.0%	-3.3%	0.022%
11/14/2024	CreativeOne Wealth LLC	6,915	$0.46M	0.0%	N/A	0.004%
11/13/2024	Clark Estates Inc. NY	54,150	$3.58M	0.7%	-7.5%	0.028%
11/13/2024	Glenmede Trust Co. NA	697,025	$46.07M	0.2%	-18.4%	0.362%
11/13/2024	Bridgewater Associates LP	308,632	$20.40M	0.1%	+142.8%	0.160%
11/13/2024	Freedom Investment Management Inc.	16,092	$1.06M	0.1%	N/A	0.008%
11/13/2024	CKW Financial Group	800	$54K	0.0%	-20.0%	0.000%
11/13/2024	BNP Paribas Financial Markets	184,804	$12.22M	0.0%	-7.8%	0.096%
11/13/2024	Brooklyn Investment Group	454	$30K	0.0%	N/A	0.000%
11/13/2024	Quantbot Technologies LP	5,450	$0.36M	0.0%	-55.6%	0.003%
11/13/2024	D.A. Davidson & CO.	3,225	$0.21M	0.0%	-7.2%	0.002%
11/13/2024	FMR LLC	1,320,469	$87.28M	0.0%	-26.1%	0.685%
11/13/2024	Patton Albertson Miller Group LLC	78,743	$5.21M	0.7%	-4.7%	0.041%
11/13/2024	The Manufacturers Life Insurance Company	165,537	$10.94M	0.0%	+33.3%	0.086%
11/13/2024	Bank of Montreal Can	194,736	$12.82M	0.0%	-10.6%	0.101%
11/13/2024	Dynamic Technology Lab Private Ltd	5,059	$0.33M	0.0%	-70.9%	0.003%
11/13/2024	Fisher Asset Management LLC	11,522	$0.76M	0.0%	+24.5%	0.006%
11/13/2024	Daiwa Securities Group Inc.	20,649	$1.37M	0.0%	-4.9%	0.011%
11/12/2024	Summit Trail Advisors LLC	5,470	$0.36M	0.0%	N/A	0.003%
11/12/2024	Cerity Partners LLC	19,157	$1.27M	0.0%	+40.7%	0.010%
11/12/2024	Great Valley Advisor Group Inc.	5,903	$0.39M	0.0%	-11.9%	0.003%
11/12/2024	Citigroup Inc.	166,550	$11.01M	0.0%	-42.8%	0.086%
11/12/2024	Charles Schwab Investment Management Inc.	1,609,220	$106.37M	0.0%	+29.2%	0.835%
11/12/2024	Banco Santander S.A.	94,418	$6.24M	0.1%	-20.4%	0.049%
11/12/2024	Blackhawk Capital Partners LLC.	4,812	$0.32M	0.2%	-62.5%	0.002%
11/12/2024	Massachusetts Financial Services Co. MA	71,691	$4.74M	0.0%	N/A	0.037%
11/9/2024	Cypress Capital Group	14,695	$0.97M	0.1%	N/A	0.008%
11/9/2024	Intech Investment Management LLC	62,256	$4.12M	0.0%	-41.4%	0.032%
11/8/2024	Grandfield & Dodd LLC	19,525	$1.29M	0.1%	+3.2%	0.010%
11/8/2024	Advisors Asset Management Inc.	15,244	$1.01M	0.0%	+2.6%	0.008%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	582,107	$38.48M	0.2%	-48.5%	0.302%
11/8/2024	Commerce Bank	9,221	$0.61M	0.0%	N/A	0.005%
11/8/2024	Northwest Bancshares Inc.	66,434	$4.39M	0.7%	-7.6%	0.034%
11/8/2024	PNC Financial Services Group Inc.	30,649	$2.03M	0.0%	+42.1%	0.016%
11/8/2024	B. Metzler seel. Sohn & Co. Holding AG	4,421	$0.29M	0.0%	N/A	0.002%
11/8/2024	Banque Cantonale Vaudoise	8,730	$0.58M	0.0%	+336.1%	0.005%
11/8/2024	Princeton Capital Management LLC	4,098	$0.27M	0.1%	-43.9%	0.002%
11/8/2024	Prospera Financial Services Inc	3,788	$0.25M	0.0%	-43.5%	0.002%
11/7/2024	Meeder Asset Management Inc.	2,811	$0.19M	0.0%	N/A	0.001%
11/7/2024	Quest Partners LLC	2,284	$0.15M	0.0%	-67.0%	0.001%
11/7/2024	TrinityPoint Wealth LLC	20,638	$1.36M	0.2%	+3.4%	0.011%
11/7/2024	Swiss National Bank	483,274	$31.94M	0.0%	+0.9%	0.251%
11/7/2024	Thrivent Financial for Lutherans	7,332	$0.49M	0.0%	-1.9%	0.004%
11/7/2024	AM Squared Ltd	1,800	$0.12M	0.3%	+125.0%	0.001%
11/6/2024	Mutual of America Capital Management LLC	19,729	$1.30M	0.0%	-2.9%	0.010%
11/6/2024	Seizert Capital Partners LLC	94,342	$6.24M	0.3%	+12.4%	0.049%
11/6/2024	Mizuho Securities USA LLC	2,000,100	$132.21M	0.3%	+13,814.7%	1.038%
11/6/2024	Kentucky Retirement Systems Insurance Trust Fund	4,733	$0.31M	0.0%	-21.3%	0.002%
11/6/2024	Kentucky Retirement Systems	11,136	$0.74M	0.0%	-20.7%	0.006%
11/6/2024	Empowered Funds LLC	22,081	$1.46M	0.0%	-79.8%	0.011%
11/6/2024	CIBC Asset Management Inc	25,303	$1.67M	0.0%	+2.9%	0.013%
11/6/2024	Tokio Marine Asset Management Co. Ltd.	6,406	$0.42M	0.0%	+21.8%	0.003%
11/6/2024	Metis Global Partners LLC	7,150	$0.47M	0.0%	-3.3%	0.004%
11/6/2024	KBC Group NV	1,161,053	$76.75M	0.2%	-32.7%	0.603%
11/5/2024	Haverford Trust Co	7,796	$0.52M	0.0%	+1.8%	0.004%
11/5/2024	Victory Capital Management Inc.	107,456	$7.10M	0.0%	-57.3%	0.056%
11/5/2024	Sumitomo Mitsui Trust Group Inc.	483,699	$31.97M	0.0%	-9.3%	0.251%
11/5/2024	GSA Capital Partners LLP	6,453	$0.43M	0.0%	+26.5%	0.003%
11/4/2024	Venturi Wealth Management LLC	988	$65K	0.0%	N/A	0.001%
11/4/2024	Los Angeles Capital Management LLC	209,795	$13.87M	0.1%	-43.4%	0.109%
11/4/2024	State of New Jersey Common Pension Fund D	60,559	$4M	0.0%	-13.9%	0.031%
11/4/2024	Crossmark Global Holdings Inc.	25,079	$1.66M	0.0%	+1.1%	0.013%
11/2/2024	Covestor Ltd	3,993	$0.26M	0.2%	-13.0%	0.002%
11/1/2024	Applied Finance Capital Management LLC	471,687	$31.18M	0.8%	-5.6%	0.245%
11/1/2024	Capital Performance Advisors LLP	686	$45K	0.0%	N/A	0.000%
10/31/2024	ARK Investment Management LLC	211,536	$13.98M	0.1%	-46.9%	0.110%
10/31/2024	JB Capital LLC	46,628	$3.08M	0.2%	+2.5%	0.024%
10/31/2024	Principal Financial Group Inc.	220,750	$14.59M	0.0%	-10.9%	0.115%
10/30/2024	Amalgamated Bank	31,585	$2.09M	0.0%	-16.9%	0.016%
10/30/2024	Sentry Investment Management LLC	562	$37K	0.0%	-39.7%	0.000%
10/30/2024	Gulf International Bank UK Ltd	14,851	$0.98M	0.0%	-5.4%	0.008%
10/30/2024	Greenwood Capital Associates LLC	6,546	$0.43M	0.1%	N/A	0.003%
10/30/2024	Asset Management One Co. Ltd.	88,887	$5.88M	0.0%	-2.2%	0.046%
10/29/2024	Forum Financial Management LP	3,503	$0.23M	0.0%	N/A	0.002%
10/29/2024	Robeco Institutional Asset Management B.V.	1,265,966	$83.68M	0.2%	+5.9%	0.657%
10/29/2024	Van ECK Associates Corp	134,881	$8.79M	0.0%	-16.7%	0.070%
10/29/2024	Janney Montgomery Scott LLC	26,556	$1.76M	0.0%	-9.6%	0.014%
10/28/2024	Cambiar Investors LLC	157,303	$10.40M	0.4%	-0.2%	0.082%
10/25/2024	First Trust Direct Indexing L.P.	28,882	$1.91M	0.1%	-3.6%	0.013%
10/25/2024	New York State Teachers Retirement System	173,895	$11.49M	0.0%	-18.0%	0.077%
10/25/2024	Integrated Advisors Network LLC	14,631	$0.97M	0.0%	N/A	0.007%
10/25/2024	China Universal Asset Management Co. Ltd.	37,043	$2.45M	0.3%	+40.2%	0.016%
10/25/2024	abrdn plc	66,238	$4.42M	0.0%	+3.7%	0.029%
10/24/2024	Nisa Investment Advisors LLC	30,256	$2M	0.0%	-5.0%	0.013%
10/24/2024	First Financial Bankshares Inc	39,802	$2.63M	0.1%	+4.0%	0.018%
10/24/2024	Ellis Investment Partners LLC	19,756	$1.31M	0.3%	+5.1%	0.009%
10/24/2024	State of Alaska Department of Revenue	34,059	$2.25M	0.0%	-36.2%	0.015%
10/24/2024	DekaBank Deutsche Girozentrale	160,078	$10.49M	0.0%	+24.8%	0.071%
10/24/2024	Wealth Enhancement Advisory Services LLC	11,533	$0.76M	0.0%	+22.8%	0.005%
10/24/2024	Forsta AP Fonden	102,900	$6.80M	0.1%	+51.1%	0.046%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	20,935	$1.38M	0.0%	+26.0%	0.009%

Data available starting January 2016

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States and internationally. The company offers JAKAFI (ruxolitinib) for treatment of intermediate or high-risk myelofibrosis, polycythemia vera, and steroid-refractory acute graft-versus-host disease; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab) for relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in liquid and solid tumor types; ICLUSIG (ponatinib) to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; and ZYNYZ (retifanlimab-dlwr) to treat adults with metastatic or recurrent locally advanced Merkel cell carcinoma, as well as OPZELURA cream for treatment of atopic dermatitis. Its clinical stage products include retifanlimab under Phase 3 clinical trials for squamous cell carcinoma of the anal canal and non-small cell lung cancer; axatilimab, an anti-CSF-1R monoclonal antibody under Phase 2 that is being developed as a therapy for patients with chronic GVHD; INCA033989 to inhibit oncogenesis; INCB160058, which is being developed as a disease-modifying therapeutic; and INCB99280 and INCB99318 for the treatment solid tumors. The company also develops INCB123667, INCA32459, and INCA33890, as well as Ruxolitinib cream, Povorcitinib, and INCA034460. It has collaboration out-license agreements with Novartis and Lilly; in-license agreements with Agenus, Merus, MacroGenics, and Syndax; and collaboration and license agreement with China Medical System Holdings Limited for the development and commercialization of povorcitinib. The company sells its products to specialty, retail, and hospital pharmacies, distributors, and wholesalers. The company was formerly known as Incyte Genomics Inc and changed its name to Incyte Corporation in March 2003. Incyte Corporation was incorporated in 1991 and is headquartered in Wilmington, Delaware.

Today's Range

Now: $78.96

$78.92

$80.46

50 Day Range

MA: $68.40

$61.26

$83.38

52 Week Range

Now: $78.96

$50.35

$83.95

Volume

719,997 shs

Average Volume

2,329,990 shs

Market Capitalization

$15.21 billion

P/E Ratio

564.04

Dividend Yield

N/A

Beta

0.71

Who are the company insiders with the largest holdings of Incyte?: Incyte's top insider shareholders include:
Steven H Stein (EVP)
Maria E Pasquale (EVP)
Barry P Flannelly (EVP)
Vijay K Iyengar (EVP)
Jonathan Elliott Dickinson (EVP)
Thomas Tray (Insider)
Learn More about top insider investors at Incyte.
Who are the major institutional investors of Incyte?: Incyte's top institutional investors include:
Mizuho Securities USA LLC — 1.04%
Charles Schwab Investment Management Inc. — 0.84%
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.72%
FMR LLC — 0.69%
Robeco Institutional Asset Management B.V. — 0.66%
KBC Group NV — 0.60%
Learn More about top institutional investors of Incyte stock.
Which institutional investors are selling Incyte stock?: During the previous quarter, INCY stock was sold by these institutional investors:
KBC Group NV
Connor Clark & Lunn Investment Management Ltd.
FMR LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Allspring Global Investments Holdings LLC
ARK Investment Management LLC
Los Angeles Capital Management LLC
Glenmede Trust Co. NA
In the last year, company insiders that have sold Incyte company stock include:
Steven H Stein (EVP)
Maria E Pasquale (EVP)
Barry P Flannelly (EVP)
Vijay K Iyengar (EVP)
Learn More investors selling Incyte stock.
Which institutional investors are buying Incyte stock?: Within the previous quarter, INCY stock was purchased by institutional investors including:
Mizuho Securities USA LLC
Charles Schwab Investment Management Inc.
Bridgewater Associates LP
Massachusetts Financial Services Co. MA
Robeco Institutional Asset Management B.V.
The Manufacturers Life Insurance Company
Verition Fund Management LLC
Zurcher Kantonalbank Zurich Cantonalbank